Methylated DNA in mammals is associated with tran scriptional repression and nuclease resistant chromatin. In this review we discuss how these effects may be medi ated by proteins that bind to methylated DNA.
Summary
Methylated DNA in mammals is associated with tran scriptional repression and nuclease resistant chromatin. In this review we discuss how these effects may be medi ated by proteins that bind to methylated DNA.
Méthylation of DNA is essential in mammals
In mammals approximately 70% of all CpGs are methy lated at the 5 position of cytosine. It is not clear what the functional role of this modification is, but it has been recently shown by gene targeting experiments that méthyl ation o f DNA is necessary for mouse development (Li et al., 1992) . Mutant mouse embryos that have reduced levels (1/3 of wild type) of genomic m5C were generated by intro ducing a mutation into the DNA methyltransferase (MTase) gene. Homozygous mutant embryos were stunted and died at midgestation. A similar reduction of m5C in the DNA of embryonic stem (ES) cells had no effect on their ability to survive in tissue culture. This suggests that reduced levels of MTase cause abnormal development.
How might decreased levels of DNA méthylation cause embryonic lethality? There is much evidence that méthyl ation near promoters leads to stable inactivation of the asso ciated gene, and in one case (X-inactivation in placental mammals) we know that the stability of repression in the organism is due in part to méthylation (see Riggs and Pfeifer, 1992) . For example the CpG island-containing genes on the X chromosome become methylated following X chromosome inactivation in eutherian mammals (Grant and Chapman, 1988) . The equivalent CpG island genes remain non-methylated on the active X chromosome. A similar process of méthylation associated inactivation occurs to retroviral proviruses following infection of early mouse embryos (Jâhner et al., 1982) . In both of these cases there is some evidence that the genes become inactivated prior to or at the onset of méthylation (Gautsch and Wilson, 1983; Lock et al., 1987; Singer-Sam et al., 1990) . Although DNA méthylation may not be directly responsible for the initial inactivation event, it is seen as integral to the main tenance of gene repression (Pfeifer et al., 1990b) . There may well be other cases where the repressive effects of méthylation have been harnessed for the benefit of con-trolling gene expression during development. If we assume that méthylation is functioning as a transcriptional repres sor in the developing embryo then one possibility is that high levels of MTase are required to repress genes stably whose inappropiate expression could cause embryonic lethality. These 'genes' may correspond to normally inac tivated retroviruses (Jâhner et al., 1982) , retroposons and genes that are usually tissue-specific in their expression.
At this point it is also worth considering that DNA méthylation has been proposed to have numerous other roles in the regulation of chromatin activity with respect to DNA repair, recombination and replication. Perturbation of these processes could also have lethal consequences for the developing embryo. For example, the mouse major satel lite sequence is undermethylated in the embryonal carci noma-derived F9 cells and is shifted in its replication timing from late to early S-phase in comparison with its methy lated counterpart (Selig et al., 1988) . This may implicate méthylation in the maintainance of satellite DNA sequences in a late replicating mode in differentiated cells. It has also recently been shown that CpG méthylation inhibits recom bination between V(D)J substrates maintained on minichro mosomes (Hsieh and Lieber, 1992) . Likewise transcrip tionally active DNA promoter regions are preferentially repaired after exposure to DNA damaging agents in com parison with inactive DNA regions (Mellon et al., 1986) . Thus a more liberal interpretation of the function of DNA méthylation would be as a chromatin repressor rather than solely as a transcriptional repressor.
The observation that ES cells can survive in tissue cul ture with reduced amounts of m5C in their DNA implies that embryonic cells are less dependent on DNA méthyl ation than somatic cells. It would of be interest to know whether somatically derived cell lines carrying the same MTase mutation could also maintain viability in culture. In fact many established cell lines have high levels of de novo méthylation at the promoter regions of genes that are prob ably not required by the cell for growth on a plastic dish (Jones et al., 1990; Antequera et al., 1990) . A somatically derived cell line may find it selectively more advantageous to utilize the inhibitory effects of DNA methylation on genes that are dispensable in culture.
How does methylation inhibit transcription?
There is a variety of evidence in the literature which suggests that the presence of DNA methylation at gene pro moters can inhibit transcription in two possible ways (Watt and Molloy, 1988; Boyes and Bird, 1991) . One model pro poses that CpG methylation can interfere with transcription directly by modifying the binding site (through methyl ation) of transcription factors so that they can no longer bind their cognate sequences. Alternatively there are fac tors in the nucleus which specifically bind methylated DNA and thereby deny transcription factors access to gene pro motors.
In the first case we know of some transcription factors that are sensitive to methylation in this way (Kovesdi et al., 1987; W att and M olloy,1988; Iguchi-Ariga and Schaffner, 1989; Shen and Whitlock, 1989; Comb and Goodman, 1990) . Two factors detected in HeLa cells are unable to bind to sites containing methyl-CpG and are thus unable to stimulate transcription from the adenovirus late and E2 pro moters (Kovesdi et al., 1987; W att and Molloy, 1988) . On the other hand the general transcription factor S pl binds equally well to methylated and non-methylated sites and stimulates transcription from both kinds of template (Har rington et al., 1988; Hoeller et al., 1988) . It should also be recognised that many transcription factors do not contain the dinucleotide CpG in their recognition sequence, so it is difficult to envisage how methylation could directly inhibit the binding o f such factors.
Current evidence strongly favours the second idea that repression is mediated by proteins that bind to DNA con taining methyl-CpG (Boyes and Bird, 1991; Levine et al., 1991) . Early evidence supporting such a mechanism came from microinjection studies with the methylated Herpes simplex virus thymidine kinase (tk) gene (Buschausen et al., 1987) . In this case the methylated tk gene was tran scribed normally for about 8 hours until repressed. The timing of inhibition coincided with assembly of the methy lated tk gene into chromatin. This suggested that the inhi bition was indirect and may involve proteins that bind to methylated DNA. Additional evidence for the existence of such factors in mammalian nuclei was that m5C (but not thymidine) in chromatin is refractory to digestion by microccoccal nuclease (Solage and Cedar, 1978) and to nucleases that can cleave at CpG (Hansen et al., 1988; Ante quera et al., 1989) . Sequences artificially methylated in vitro are transcriptionally repressed when transfected into cells and also adopt a nuclease-insensitive chromatin structure (Keshet et al., 1986) . A refinement of the indirect model which can accommodate both gene repression and altered chromatin would be that methyl-CpG binding proteins, or MeCPs, bind to a methylated gene leading to an altered chromatin structure which would in turn deny access to the transcription machinery (Lewis and Bird, 1991) . Binding of MeCPs in this model could also account for the other chro matin suppressor effects associated with DNA methylation such as late replication and inhibition of recombination.
Methyl-CpG binding proteins (MeCPs)
W e have detected two such proteins (MeCPs 1 and 2) by conventional biochemical techniques in mammalian and avian nuclei. We have purified, cloned and sequenced one of these (MeCP2). M eCPl binds in vitro to DNA contain ing at least 12 symmetrically methylated CpGs (Meehan et al., 1989) , while MeCP2 can bind to a single methylated CpG pair (Lewis et al., 1992) . Neither protein will bind sig nificantly to DNA that contains m5C in a sequence other than CpG (Meehan et al., 1989 (Meehan et al., , 1992 . Furthermore, nei ther protein shows an affinity for TpG, which also carries a methyl group at the 5 position of the pyrimidine ring pre ceding a G (but is not self complementary). The relaxed sequence specificity and widespread tissue distribution of these proteins makes them likely candidates for mediators o f the effects of methylation. M eCPl is of relatively low abundance (about 5000 molecules per nucleus), and is loosely bound, whereas MeCP2 is comparatively abundant (about 200,000 molecules per nucleus) and is only released from chromatin by high salt concentrations. Both proteins are deficient in embryonal carcinoma (EC) and stem (ES) cells.
A third methylated DNA binding protein has been detected in human placenta but this protein is highly sequence-specific (Huang et al., 1984; W ang et al., 1986) and may actually correspond to a methylation-insensitive transcription factor. This protein is therefore unlikely to be involved in general methylation-mediated inhibition. It has also been reported that histone H I binding to methylated DNA in vitro can inhibit the normally methylation-insensi tive restriction enzyme M spl (Higurashi and Cole, 1991) .
Biological significance of MeCPs
Studies of M eC Pl have implicated it in methylation-associated gene inactivation. The expression of the X-linked mouse PGK1 gene promoter can be inhibited by methyl ation in transcription extracts and in cell lines which con tain M eCPl (Boyes and Bird, 1991) . Expression can be restored by competition with methylated DNA substrates which are specific for M eC Pl. In addition, methylated genes are not efficiently repressed in ES and EC cell lines or extracts which lack MeCPs (Boyes and Bird, 1991; Levine et al., 1991) . Histone H I is present in ES and EC cell lines and so can be ruled out as a methylation-specific transcriptional repressor.
Methylation can also inhibit transcription directly by interference of site-specific methylation within a recogni tion site for a transcription factor with the binding o f that factor. Although we know of some transcription factors that are blocked in this way (see earlier), it is striking that out o f seven fully methylated promoters studied so far, none are inhibited strongly under conditions where M eC Pl is absent Bird, 1991, 1992; Levine et al., 1991) . Thus the predom inant repression m echanism appears to w ork via M e C P l. In keeping with this, several studies have show n that transcription is sensitive to any m ethylation near the prom oter, not ju st to specific methyl groups at key sites (M urray and G rosveld, 1987) .
A lthough purified M eCP2 has a preference for DNA sym m etrically m ethylated at the dinucleotide CpG , it cannot selectively inhibit transcription from CpG -rich m ethylated DN A tem plates in vitro (M eehan et al., 1992) . Thus the biological significance o f M eC P2 is presently uncertain. In addition to its high specificity for m ethyl-C pG pairs, the protein contains dom ains that can interact w ith low affin ity with non-m ethylated D NA sequences. T he latter are readily com peted out in the presence o f excess non-m ethy lated DNA, im plying that they do not overlap the protein dom ain responsible for m ethyl-C pG binding (M eehan et al., 1992) . It w ould be prem ature to conclude, how ever, that M eCP2 is not involved in transcriptional repression. N ucle ase treatm ent o f chrom atin indicates that M eCP2 is bound to chrom atin, but the transcription experim ents w ere car ried out in histone-free extracts in w hich chrom atin cannot form (M eehan et al., 1992) . If the natural ligand for M eCP2 is chrom atin, as is the case for histone H I (W olffe, 1990), this could explain our failure to observe specific effects.
Evidence that M eCP2 is associated w ith m ethyl-C pG s in vivo relies upon in situ localisation o f the protein using antibodies. A polyclonal antibody raised against purified, denatured rat M eCP2 cross reacts with the hom ologous pro tein from m ouse (Fig. 1) . The m obility o f the reacting pro tein is identical to that o f the m ouse M eC P2-like activity (80 kD) detected by southw estern assay (M eehan et al., 1992) . A ntibodies against M eCP2 localise preferentially to centrom eric heterochrom atin regions, although euchrom atic chrom osom e arm s are also stained ( Fig. 2 ; see also Lew is et al., 1992) . Pre-im m une serum did not stain the chrom o som es significantly (Fig. 2) . M ore than half o f the m ethylCpG s in the m ouse genom e are located in the m ajor satel lite D N A w hich is concentrated in centrom eric heterochrom atin (M anuelides, 1981; H orz and A ltenberger, 1981) , as calculated from the know n distribution o f CpGs in satellite and bulk DNA. T he asym m etrical distribution o f m ethyl-C pG can also be visualised directly using anti bodies against 5-m ethylcytosine, w hich preferentially stain regions o f pericentrom eric heterochrom atin (M iller et al., 1974) . Thus M eCP2 colocalizes w ith chrom osom al regions that are know n to be rich in m ethyl-C pG . W e could also dem onstrate that the m ethylated form of the 234-bp satel lite m onom er D N A was a good substrate for M eCP2 by southw estern analysis (Lew is et al., 1992) but did not bind M eC P l in the bandshift assay (S. Cross, unpublished data).
O ne speculation for M eCP2 function m ay be in the genom e-w ide protection o f m ethyl-C pG s against nucleases, as it is m uch m ore abundant and m ore tightly bound in the nucleus than M e C P l. Brain nuclei, w hich have the highest levels o f M eCP2, show particularly striking protection of m ethyl-C pG s against nucleases (A ntequera et al., 1989) . Conversely PC 13 cells, w hich have very reduced levels o f M eC P l and M eCP2, show m arkedly reduced levels o f p ro tection (A ntequera et al., 1989; L evine et al., 1991) . As stated earlier, it has been reported that histone HI binding to m ethylated D N A in vitro can inhibit the norm ally m ethylation-insensitive restriction enzym e M spl, im plying that H I could be responsible for nuclease protection in nuclei (Higurashi and Cole, 1991) . H ow ever, this observa tion does not explain the different levels o f protection seen betw een m ouse brain and PC 13 nuclei, w hich appear to have com parable levels o f histone H I, unless histone HI is very different betw een PC 13 cells and brain. A s yet, we have been unable to detect a preference for binding to m ethylated DNA by histone H I in either the bandshift or southw estern assays.
G enom ic sequencing studies on the hum an PGK1 p ro m oter have not provided any evidence for binding by M eC Ps in vivo (Pfeifer et al., 1990a; Pfeifer and Riggs, 1991) . H ow ever differences w ere observed betw een the PGK1 prom oters on the active X chrom osom e (Xa) and the inactive X chrom osom e (Xi). T he unm ethylated X a pro m oter was free o f nucleosom es but did show several foot prints indicative o f transcription factors (including S p l), w hereas the m ethylated DNA (60 out o f a possible 61 CpG sites) o f the Xi prom oter w as w rapped around positioned particles, w hich are presum ed to be nucleosom es. Interest ingly the phased nucleosom es on the Xi prom oter covered m ost o f the M sp l sites tested for nuclease sensitivity.
The lack o f footprints attributable to M eC Ps over the m ethylated PGK1 prom oter does not prove their absence. If M eC Ps bind random ly and w eakly with m ethyl-CpG s then it may be difficult to detect their interaction w ith m ethylated D NA by present m ethods (Pfeifer and Riggs, 1991) . W e know that M eCP2 binding to chrom atin is very sensitive to nuclease treatm ent (M eehan et al., 1992) . This m ay account for the failure to d etect M eC Ps interacting with m ethyl-CpG s o f PGK1 on the X i using D N ase I. There MeCP2 was detected by indirect immunofluorescence of nuclei and metaphase chromosomes from mouse fibroblasts (cell line L929) using Ab76. Antibody labelling was carried out as described by Jeppesen et al. (1992) and modified by Lewis et al. (1992) . AntiMeCP2 immunofluorescence (A) is confined to nuclei and metaphase chromosomes, where it is particularly enriched in the heterochromatic domains but there is also significant staining on the euchromatic arms. (B) The same field is observed using the DNA fluorochrome Hoechst 33258 and shows the brightly fluorescent heterochromatin in both nuclei and chromosomes. The fluorescent heterochromatin corresponds with the concentration of anti-MeCP2 immunofluorescence. This is especially striking in the case of a marker multicentric chromosome (arrowhead) where each block o f residual pericentromeric heterochromatin is immunofluorescently labelled. (D,E) A similar preparation o f mouse L929 cells was labelled under identical conditions to those described for A and B using pre immune rabbit serum instead of AB76. Only background non-specific FITC fluorescence is evident (C). The same field observed by Hoechst 33258 fluorescence is shown in D.
is no evidence that m éthylation o f D N A favours nucleosom e form ation or determ ines positioning (Felsenfeld et al., 1982; Drew and M cCall, 1987) . W ithout M eCPs it is dif ficult to account for the reduced M s p i resistance in M eCP deficient cells (A ntequera et al., 1989; Levine et al., 1991) . This problem m ay be overcom e if M eCPs guide nucleosom e form ation so that m ethyl-CpG s are rendered nuclease resistant (see Riggs and Pfeifer, 1992 , and below).
Mechanisms of methylation-mediated repression
The sim ilarities and differences betw een M eC P l and M eCP2 suggest a w orking model for their roles in m ethylation-m ediated repression. M eC P l is o f relatively low abundance (about 5000 m olecules per nucleus), and is loosely bound, w hereas M eCP2 is com paratively abundant (about 200,000 m olecules per nucleus) and is only released from chrom atin by high salt concentrations. M eC P l may thus com pete with transcription factors in the nucleoplasm for binding to m ethylated D N A , the outcom e depending on the density o f m ethylation and the affinity o f the factors (Boyes and Bird. 1992; Bird, 1992) . W e hypothesise that binding to M eC P l then guides the DNA into a hete rochrom atic structure involving stable association with M eCP2. How this m ight happen is unknow n, but it proba bly occurs at DNA replication, since the resistance o f m ethylated D N A to nucleases is know n to increase dra matically at this time. Hsieh and Lieber (1992) showed that high-density CpG methylation prevents the V(D)J joining reaction in lymphocytes, but only after DNA replication has taken place. Resistance to M spl was much higher follow ing replication, consistent with the idea that methylation guides the replicating DNA into a 'heterochromatic' struc ture.
Although direct interference of methyl-CpG with tran scription factor binding may not be the primary mechanism of methylation-mediated repression, it may contribute to the MeCP-mediated repression described above. The three parameters which determine the effects of DNA methyl ation on gene expression are: (1) location of the methylated sites relative to the promoter; (2) density of methylated sites; (3) promoter strength (Boyes and Bird, 1992; Bird, 1992) . Direct blockage of a factor which contributes to pro moter strength may weaken certain promoters, and may therefore bias the competition between M eC Pl binding and transcription factor binding in favour of M eC Pl. In this hypothetical case, direct and indirect inhibition mecha nisms, which were thought to be mutually exclusive alter natives, would work together to bring about repression.
Conclusions
MeCPs have been detected in organisms which maintain a large fraction of their genomes in a methylated state, includ ing mammals, birds and plants (Meehan et al., 1992; Zhang et al., 1989) . Thus the interaction of MeCPs with methy lated DNA may be a common strategy in regulating chro matin activity in these types of organisms. This idea is rein forced by the fact that we have not detected M eCPs in organisms with genomes which have either very reduced methylated DNA fractions or no detectable methylated DNA (eg. Drosophila) (Meehan et al., 1992) . Our ability to isolate and clone these proteins should allow us to recon struct in vitro the interaction of chromatin and MeCPs, and investigate how this could influence chromatin structure and activity. O f prime importance will be the generation of mutations in the M eCP loci of mice and the comparison of the phenotype o f such mutants with the MTase mutation (Li et al., 1992) . We might expect that loss of MeCPs and loss of MTase should give similar phenotypes.
